aCT1
Peptideexperimental
Clinical trial activity
7 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02666131)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- granexin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04684121 | Phase 2 | Dec 1, 2021 | Department of Defense, FirstString Research, Inc. |
| NCT05031806 | Phase 1 | Sep 28, 2021 | Department of Defense, FirstString Research, Inc. |
| NCT04331080 | Phase 2/Phase 3 (Phase 3) | Apr 30, 2020 | FirstString Research, Inc. |
| NCT02652754 | Phase 1 | Sep 1, 2015 | FirstString Research, Inc., Medical University of South Carolina, Spartanburg Regional Healthcare System |
| NCT02652572 | Phase 1 | Sep 1, 2015 | FirstString Research, Inc., Medical University of South Carolina, Spartanburg Regional Healthcare System |
| NCT02667327 | Phase 3 | Jul 1, 2015 | FirstString Research, Inc., INC Research, Medical University of South Carolina |
| NCT02666131 | Phase 3 | Jul 1, 2015 | FirstString Research, Inc., INC Research, Medical University of South Carolina |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FirstString Research, Inc. | For profit | 7 | 7 | 3 | 2015 |
| Medical University of South Carolina | Academic/Hospital | 4 | 0 | 2 | 2015 |
| Department of Defense | Government | 2 | 0 | 2 | 2021 |
| INC Research | For profit | 2 | 0 | 1 | 2015 |
| Spartanburg Regional Healthcare System | Academic/Hospital | 2 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1